Src is the primary target of aripiprazole, an atypical antipsychotic drug, in its anti-tumor action

Aripiprazole (ARP) is an atypical anti-psychotic drug widely used to treat schizophrenia and bipolar disorder. The pharmacological effects of ARP on cancer cells are still poorly understood. In this study, anti-cancer effects of ARP on various malignant tumor cells and its molecular mechanism were f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mi Seon, Yoo, Byong Chul, Yang, Woo Seok, Han, Sang Yun, Jeong, Deok, Song, Jun Min, Kim, Kyung Hee, Aravinthan, Adithan, Kim, Ji Hye, Kim, Jong-Hoon, Kim, Seung Cheol, Cho, Jae Youl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814188/
https://www.ncbi.nlm.nih.gov/pubmed/29464048
http://dx.doi.org/10.18632/oncotarget.23192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814188/
https://www.ncbi.nlm.nih.gov/pubmed/29464048
http://dx.doi.org/10.18632/oncotarget.23192

Ejemplares similares